Active immunotherapy in spontaneous leukemia of AkR mice.
D000406:AKR murine leukemia virus; D000818:Animals; D000917:Antibody Formation; D001500:BCG Vaccine; D003520:Cyclophosphamide / Q000627:therapeutic use*; D003561:Cytarabine / Q000627:therapeutic use*; D005260:Female; D007110:Immunity, Active; D007114:Immunization; D007165:Immunosuppression Therapy; D007167:Immunotherapy; D007939:Leukemia L1210 / Q000188:drug therapy / Q000276:immunology / Q000401:mortality / Q000628:therapy*; D008297:Male; D051379:Mice; D008806:Mice, Inbred AKR; D009163:Mycobacterium bovis; D009439:Neuraminidase / Q000627:therapeutic use*; D013997:Time Factors
D001500:BCG Vaccine; D003561:Cytarabine; D003520:Cyclophosphamide; D009439:Neuraminidase